AstraZeneca PLC Stock Forecast - Relative Strength Index
| AZN Stock | USD 67.20 0.84 1.27% |
AstraZeneca Stock Forecast is based on your current time horizon. Although AstraZeneca PLC's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of AstraZeneca PLC's systematic risk associated with finding meaningful patterns of AstraZeneca PLC fundamentals over time.
AstraZeneca |
| Check AstraZeneca PLC Volatility | Backtest AstraZeneca PLC | Trend Details |
AstraZeneca PLC Trading Date Momentum
| On November 25 2024 AstraZeneca PLC ADR was traded for 66.40 at the closing time. Highest AstraZeneca PLC's price during the trading hours was 66.57 and the lowest price during the day was 65.86 . The net volume was 6.6 M. The overall trading history on the 25th of November contributed to the next trading period price boost. The overall trading delta to the next next day price was 1.17% . The overall trading delta to current price is 1.62% . |
| Compare AstraZeneca PLC to competition |
Other Forecasting Options for AstraZeneca PLC
For every potential investor in AstraZeneca, whether a beginner or expert, AstraZeneca PLC's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. AstraZeneca Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in AstraZeneca. Basic forecasting techniques help filter out the noise by identifying AstraZeneca PLC's price trends.AstraZeneca PLC Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AstraZeneca PLC stock to make a market-neutral strategy. Peer analysis of AstraZeneca PLC could also be used in its relative valuation, which is a method of valuing AstraZeneca PLC by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
AstraZeneca PLC ADR Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of AstraZeneca PLC's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of AstraZeneca PLC's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
AstraZeneca PLC Market Strength Events
Market strength indicators help investors to evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By undertsting and applying AstraZeneca PLC stock market strength indicators, traders can identify AstraZeneca PLC ADR entry and exit signals to maximize returns.
AstraZeneca PLC Risk Indicators
The analysis of AstraZeneca PLC's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in AstraZeneca PLC's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting astrazeneca stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.06 | |||
| Standard Deviation | 1.5 | |||
| Variance | 2.24 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with AstraZeneca PLC
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AstraZeneca PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will appreciate offsetting losses from the drop in the long position's value.Moving together with AstraZeneca Stock
| 0.87 | VALN | Valneva SE ADR | PairCorr |
| 0.72 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.88 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.92 | LLY | Eli Lilly Sell-off Trend | PairCorr |
Moving against AstraZeneca Stock
| 0.88 | GILD | Gilead Sciences | PairCorr |
| 0.87 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
| 0.82 | NAMS | NewAmsterdam Pharma | PairCorr |
| 0.57 | LPCN | Lipocine | PairCorr |
| 0.56 | PHVS | Pharvaris BV | PairCorr |
The ability to find closely correlated positions to AstraZeneca PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AstraZeneca PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AstraZeneca PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AstraZeneca PLC ADR to buy it.
The correlation of AstraZeneca PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AstraZeneca PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AstraZeneca PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AstraZeneca PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of AstraZeneca PLC to cross-verify your projections. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.034 | Dividend Share 2.97 | Earnings Share 2.08 | Revenue Per Share 2.7424 | Quarterly Revenue Growth 0.18 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.